Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery

被引:39
作者
Casele, Holly [1 ]
Grobman, William A. [1 ]
机构
[1] Northwestern Univ, Sch Med, Sect Maternal Fetal Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA
关键词
D O I
10.1097/01.AOG.0000227780.76353.05
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To evaluate the cost-effectiveness of thromboprophylaxis at cesarean delivery with intermittent pneumatic compression. METHODS: A decision tree model using Markov analysis was developed to compare two approaches to perioperative care at the time of cesarean delivery: 1) no use of perioperative thromboprophylaxis and 2) the use of intermittent pneumatic compression for thromboprophylaxis at the time of cesarean delivery. Postcesarean deep venous thrombosis was estimated to occur in 0.7% of patients (75% of whom were asymptomatic), and result in a 9% chance of postthrombotic syndrome. Mechanical prophylaxis was assumed to decrease the risk of deep venous thrombosis by 70% and to cost $120. Probability of morbidity and mortality of venous thromboembolism as well as anticoagulation and the costs and utilities for different health state were derived from published studies. Sensitivity analysis was performed over a wide range of variable estimates. RESULTS: Using the assumptions in our base case, routine thromboprophylaxis for cesarean delivery cost $39,545 per quality-adjusted life year. One-way sensitivity analysis revealed that as long as the incidence of postcesarean deep venous thrombosis was at least 0.68%, intermittent pneumatic compression reduced the incidence of deep venous thrombosis by at least 50%, or the cost of intermittent pneumatic compression was less than $180, the cost-effectiveness of mechanical prophylaxis did not exceed $50,000 per quality-adjusted life year. CONCLUSION: Mechanical thromboprophylaxis is estimated to be a cost-effective strategy under a wide range of circumstances.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 31 条
[1]   Venous thromboembolism and pregnancy [J].
Andres, RL ;
Miles, A .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (03) :613-+
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
BARBOUR LA, 1995, OBSTET GYNECOL, V86, P621, DOI 10.1016/S0029-7844(95)80028-X
[4]   Use of antithrombotic agents during pregnancy [J].
Bates, SA ;
Greer, IA ;
Hirsh, J ;
Ginsberg, JS .
CHEST, 2004, 126 (03) :627S-644S
[5]   Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? [J].
Bonnar, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (04) :784-791
[6]   Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States [J].
Botteman, MF ;
Caprini, J ;
Stephens, JM ;
Nadipelli, V ;
Bell, CF ;
Pashos, CL ;
Cohen, AT .
CLINICAL THERAPEUTICS, 2002, 24 (11) :1960-1986
[7]   PREVENTION OF VENOUS THROMBOEMBOLISM IN GENERAL SURGICAL PATIENTS - RESULTS OF META-ANALYSIS [J].
CLAGETT, GP ;
REISCH, JS .
ANNALS OF SURGERY, 1988, 208 (02) :227-240
[8]  
CLARKEPEARSON DL, 1993, CURR OPIN OBSTET GYN, V5, P73
[9]   THE NATURAL-HISTORY OF POSTOPERATIVE VENOUS THROMBOEMBOLI IN GYNECOLOGIC ONCOLOGY - A PROSPECTIVE-STUDY OF 382 PATIENTS [J].
CLARKEPEARSON, DL ;
SYNAN, IS ;
COLEMEN, E ;
HINSHAW, W ;
CREASMAN, WT .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (08) :1051-1054
[10]   Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery [J].
Dainty, L ;
Maxwell, GL ;
Clarke-Pearson, DL ;
Myers, ER .
GYNECOLOGIC ONCOLOGY, 2004, 93 (02) :366-373